Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (11)
  • Blog post (6)
  • Page (6)
  • Single page (1)
  • Subject (1)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) October 2024 (10)
  • (-) April 2021 (15)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • December 2025 (21)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • December 2024 (13)
  • November 2024 (7)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (18)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (2)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (14)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • International (8)
  • Nanotechnology and advanced materials (6)
  • COVID-19 (5)
  • Flu and flu vaccine (1)
  • Group A Strep infections (1)
  • Respiratory infections (1)
  • Respiratory syncytial virus (RSV) (1)

25 search results

You searched for these word(s): risk assessment
  • New approach methodologies for risk assessment and safe-and-sustainable by design of nanomaterials.

    https://www.rivm.nl/en/weblog/new-approach-methodologies-for-risk-assessment-and-safe-and-sustainable-by-design-of

    … (NAMs). One focussed on the purpose of regulatory risk assessment and the other on in silico methods for the … nanomaterials, most still require validation for regulatory risk assessment purposes. Investment in validating test … NAMs are innovative technologies used in hazard and risk assessment. They aim to reduce or replace traditional …

    Publication date: 10-03-2024
  • Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon

    https://www.rivm.nl/en/news/children-aged-16-18-years-at-higher-risk-for-medical-reasons-will-receive-first-vaccination

    … born in 2003, 2004 and 2005 who are in the medical high-risk group. The first young people in this group will be … These young people are included in the medical high-risk group that the Health Council has defined for adults. … Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon …

    Publication date: 04-19-2021
  • People with a medical risk between the ages of 18-60 years invited from early May on

    https://www.rivm.nl/en/news/people-with-medical-risk-between-ages-of-18-60-years-invited-from-early-may-on

    … in the first week of May, people under 60 who are at risk for medical reasons, i.e. the group eligible for the … in this group are prioritised because they have a higher risk of severe illness from COVID-19. This includes people … to respiratory tract infections. People in the medical high-risk groups already received their invitations for COVID-19 …

    Publication date: 04-20-2021
  • New hold on vaccination with AstraZeneca for people under 60 years

    https://www.rivm.nl/en/news/new-hold-on-vaccination-with-astrazeneca-for-people-under-60-years

    … Pharmacovigilance Centre Lareb. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently investigating this … the investigation are expected on Wednesday, 7 April. A new assessment about the use of AstraZeneca will be made at that … in 1961 or later. For people aged 60 or over, the health risk from contracting COVID-19 is much higher than the risk …

    Publication date: 04-02-2021
  • Can foliar nanoforms of fertilisers be used beneficially?

    https://www.rivm.nl/en/weblog/can-foliar-nanoforms-of-fertilisers-be-used-beneficially

    … the nanospecific properties of these products when assessing the benefits and risks for crops, the environment, and human health. What are … Product Regulation, there is an increased focus on assessing the human and environmental safety aspects …

    Publication date: 10-03-2024
  • Enhancing focus on safety and sustainability could benefit the European Union’s ambition to excel in advanced materials

    https://www.rivm.nl/en/weblog/enhancing-focus-on-safety-and-sustainability-could-benefit-european-unions-ambition-to-excel

    … The past few decades of managing the uncertain risks for human and environment associated with … provide their vast experience with governing the uncertain risks of nanotechnology. They use this to emphasise the … industry, SMEs, and the public regarding potential risks and impacts of advanced materials. Key actions based …

    Publication date: 10-03-2024
  • Newsletter on COVID-19 vaccination issue 12 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/12

    … Vaccination starts for medical high risk groups … for elderly people and for people in the medical high-risk group due to neurological disorders accompanied by … has been made for four categories in the the medical high-risk groups . This applies to people whose immune system is …

    Publication date: 04-02-2021
  • Different vaccine very soon available to people under 60, instead of AstraZeneca

    https://www.rivm.nl/en/news/different-vaccine-very-soon-available-to-people-under-60-instead-of-astrazeneca

    … impact on five groups. This involves people at higher risk for medical reasons who are unable to travel, people … People at higher risk for medical reasons who are unable to travel  This …

    Publication date: 04-13-2021
  • Newsletter on COVID-19 vaccination issue 15, 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/15

    … born in 2003, 2004 and 2005 who are in a medical high-risk group . The first young people in this group will soon … in the first week of May, people under 60 who are at risk for medical reasons , i.e. the group eligible for the … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines …

    Publication date: 04-22-2021
  • Newsletter on COVID-19 vaccination issue 14 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/14

    … 60 has a direct impact on five groups: people at higher risk for medical reasons who are unable to travel, people … can be attributed to the vaccine. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency … in 2003, 2004 and 2005) who are in one of the medical high-risk groups . This vaccine has been approved for people aged …

    Publication date: 04-20-2021
  • Newsletter on COVID-19 vaccination issue 13 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/13

    … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency …

    Publication date: 04-12-2021
  • Screening Approach to the Safe-and-Sustainable-by-Design Development

    https://www.rivm.nl/en/weblog/screening-approach-to-safe-and-sustainable-by-design-development

    … by the OECD . Tier 1 of Early4AdMa is a simple screening assessment based on the NESSI score (Novelty, Exposure, … scores high, it moves to Tier 2 for a more detailed assessment of the warnings from Tier 1. The value of … be released during mat installation, posing an inhalation risk for workers. There was no expected exposure to …

    Publication date: 10-03-2024
  • Genotoxicity of titanium dioxide in cosmetics cannot be excluded

    https://www.rivm.nl/en/weblog/genotoxicity-of-titanium-dioxide-in-cosmetics-cannot-be-excluded

    … of studies should be improved to reduce uncertainty in assessment. Why does SCCS come with this advice on titanium … products revealed several shortcomings in the safety assessment. For nano-grade TiO2, more information is needed … Overall, further investigation is needed to assess the risk to the consumer from long-term repeated exposure to …

    Publication date: 10-03-2024
  • Testing of nanomaterials and advanced materials remains a challenge

    https://www.rivm.nl/en/weblog/testing-of-nanomaterials-and-advanced-materials-remains-challenge

    … testing of chemicals To enable internationally harmonised risk assessment of chemicals, research groups and regulatory …

    Publication date: 10-03-2024
  • Safety and production of COVID-19 vaccines

    https://www.rivm.nl/en/coronavirus-covid-19/vaccination/safety

    … If a vaccine receives a positive opinion in this initial assessment, a marketing authorisation will be granted by the … offering an autumn vaccination to people over 60, medical risk groups and care workers who have direct contact with … COVID-19 vaccination is advised for people in medical risk groups who could become seriously ill from COVID-19, …

    Publication date: 10-07-2024
  • Sewage as an indicator of health

    https://www.rivm.nl/en/covid-19/sewage/indicator-health

    … & Hepatology. SARS-CoV-2 in wastewater: potential health risk, but also data source. Article on …

    Publication date: 04-21-2021
  • GPs will invite under-60s with Down's syndrome or morbid obesity for GGD vaccination

    https://www.rivm.nl/en/news/gps-will-invite-under-60s-with-downs-syndrome-or-morbid-obesity-for-ggd-vaccination

    … People in these two groups have a higher risk of serious illness from COVID-19. Many of them have … receive their vaccination from week 17 on.  Other medical risk groups The other groups at higher risk for medical reasons will be vaccinated via other …

    Publication date: 04-16-2021
  • Vaccination with AstraZeneca continues for people aged 60 years and older

    https://www.rivm.nl/en/news/vaccination-with-astrazeneca-continues-for-people-aged-60-years-and-older

    … People under 60 years old who are in the medical high-risk groups; that means people with Down’s Syndrome, people … under 60. Progress on vaccination of the elderly, high-risk patients and care workers Vaccinating vulnerable target groups (the elderly, patients at higher risk for medical reasons, and care workers) as soon as …

    Publication date: 04-09-2021
  • Respiratory infections now in season

    https://www.rivm.nl/en/news/respiratory-infections-now-in-season

    … pain, headache or tiredness.  Some people are more at risk A person who has a respiratory infection can pass it on … very young children. COVID-19 and flu cause an additional risk of serious respiratory infection for older people and … these general recommendations will help you reduce the risk of passing it to others:   Are you ill? Then stay home. …

    Publication date: 10-08-2024
  • Impetigo

    https://www.rivm.nl/en/impetigo

    … washing your hands and good personal hygiene reduce the risk of impetigo. Try to avoid touching the blisters or … Impetigo is not dangerous for the unborn child. The risk of complications for pregnant women is usually no … Women who have recently given birth are at a higher risk of postpartum infection when exposed to this bacterium. …

    Publication date: 10-02-2024

Pagination

  • Current page 1
  • Page 2
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon